Apogee Therapeutics (APGE) Other Accumulated Expenses (2022 - 2024)

Apogee Therapeutics (APGE) has 3 years of Other Accumulated Expenses data on file, last reported at $1.7 million in Q3 2024.

• Quarterly Other Accumulated Expenses rose 144.65% year-over-year to $1.7 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $1.7 million (up 144.65% YoY) and the FY2023 annual result came in at $1.2 million, up 521.5% from the prior year.
• Other Accumulated Expenses grew to $1.7 million in Q3 2024 per APGE's latest filing, from $1.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.1 million in Q1 2024 and bottomed at $200000.0 in Q4 2022.
• The 3-year median for Other Accumulated Expenses is $1.2 million (2023), against an average of $1.3 million.
• The widest annual swing landed in 2023, when Other Accumulated Expenses jumped 521.5%; it then tumbled 44.94% in 2024.
• Tracing APGE's Other Accumulated Expenses over 3 years: stood at $200000.0 in 2022, then jumped by 521.5% to $1.2 million in 2023, then surged by 36.2% to $1.7 million in 2024.
• Per Business Quant, the three latest APGE Other Accumulated Expenses figures stand at $1.7 million (Q3 2024), $1.0 million (Q2 2024), and $2.1 million (Q1 2024).

Peer Comparison